Hyperhidrosis @ AAD = 7 Posters + 2 Sessions / 4 Days
The 2019 American Academy of Dermatology Annual meeting in Washington, DC (March 1-5) will feature 9 different educational opportunities related to hyperhidrosis.
Posters and lectures will cover a full update of current treatment options, new data on Qbrexza, the International Hyperhidrosis Society’s (IHhS') research on the Voice of the Hyperhidrosis Patient, and more. (Will you be at the AAD? Find out when and where to attend these presentations here.)
Here’s the complete run-down along with IHhS-related authors (note that co-authors may include other researchers not named here, but who we can’t wait to get to know better!)
Sweating: Too Much and Too Little
Hyperhidrosis: Update on Therapeutics (Presented by IHhS Co-founder and Secretary Dr. David Pariser)
Research Presentations and Posters:
Primary Axillary Hyperhidrosis: Do Gravimetric Measurements of Sweat Production Correlate with Disease Severity or Patient Characteristics? (Co-authored by our President and Co-founder Dr. Dee Anna Glaser)
An Evaluation of Anticholinergic Adverse Events with Long-Term Use of Glycopyrronium Cloth [Qbrexza], a Treatment for Primary Axillary Hyperhidrosis (Co-authored by Dr. Pariser and another of our Co-founders and board members Dr. Adelaide Hebert)
Prevalence of Anxiety, Depression and Attention Deficit Disorder (ADD) in Patients with Primary Hyperhidrosis (Co-authored by Dr. Glaser)
Managing Pitted Keratolysis through hyperhidrosis control with topical glycopyrrolate 2%
Voice of the Hyperhidrosis Patient: Symptoms, Impacts & Treatments, Insights from Large, Open FDA-Attended Meeting (Co-authored by Dr. Hebert, Dr. Glaser, Angela Ballard, RN [IHhS Communications Director], Lisa Pieretti, MBA [IHhS Executive Director and Co-founder], and Dr. Pariser.)
(Woot woot! The above is *our* poster -- meaning it’s yours, too! We gathered this qualitative data from the Patient-Focused Drug Development initiative you helped make such a success! It’s wonderful to see the results presented to this large and key audience of healthcare providers so they can better understand life with excessive sweating.)
Glycopyrronium Cloth [Qbrexza] Improves Axillary Hyperhidrosis Across a Broad Spectrum of Patients: Post Hoc Analyses of the ATMOS-1 and ATMOS-2 Phase 3 Randomized Controlled Trials in Patient Subpopulations (Co-authored by Dr. Glaser and Dr. Pariser)
Long-Term Efficacy of Glycopyrronium Cloth [Qbrexza] in Patients with Primary Axillary Hyperhidrosis (Co-authored by Dr. Glaser and Dr. Pariser)
As soon as the AAD meeting concludes, we’ll be able to provide you with the key take-aways from the hyperhidrosis-related research and lectures presented, so please stay tuned!
Huge thank you to all the dermatologists conducting these important investigations and taking the time to submit them and present them (no easy task, we know). We are also so grateful to all the AAD attendees who will make the effort to listen and learn so that the lives of hyperhidrosis sufferers can be improved.
This is medical science at work and how progress is made.
Gracias, Merci, Grazie, ありがとう, Danke sehr, Khop Khun Mak Kha, Spasiba, 감사합니다 , Takk, Mahalo, Toda, Efharisto, Whakawhetai koe, Thank you.